TBTauseef R. Butt

Tauseef R. Butt

*This is an algorithmically generated author record based on publicly available information.

Tauseef R. Butt has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protein Folding Absent Selection

    by Thomas H. LaBean, Tauseef R. Butt, Stuart A. Kauffman, Erik A. Schultes

    Biological proteins are known to fold into specific 3D conformations. However, the fundamental question has remained: Do they fold because they are biological, and evolution has selected sequences which fold? Or is folding a common trait, widespread throughout sequence space? To address this question arbitrary, unevolved, random-sequence proteins were examined for structural features found in folded, biological proteins. Libraries of long (71 residue), random-sequence polypeptides, with ensemble amino acid composition near the mean for natural globular proteins, were expressed as cleavable fusions with ubiquitin. The structural properties of both the purified pools and individual isolates were then probed using circular dichroism, fluorescence emission, and fluorescence quenching techniques. Despite this necessarily sparse “sampling” of sequence space, structural properties that define globular biological proteins, namely collapsed conformations, secondary structure, and cooperative unfolding, were found to be prevalent among unevolved sequences. Thus, for polypeptides the size of small proteins, natural selection is not necessary to account for the compact and cooperative folded states observed in nature.


  • SUMO Fusion Technology for Enhanced Protein Expression and Purification in Prokaryotes and Eukaryotes

    by Raymond J. Peroutka Iii, Steven J. Orcutt, James E. Strickler, Tauseef R. Butt

    The preparation of sufficient amounts of high-quality protein samples is the major bottleneck for structural proteomics. The use of recombinant proteins has increased significantly during the past decades. The most commonly used host, Escherichia coli, presents many challenges including protein misfolding, protein degradation, and low solubility. A novel SUMO fusion technology appears to enhance protein expression and solubility ( http://www.lifesensors.com ). Efficient removal of the SUMO tag by SUMO protease in vitro facilitates the generation of target protein with a native N-terminus. In addition to its physiological relevance in eukaryotes, SUMO can be used as a powerful biotechnology tool for enhanced functional protein expression in prokaryotes and eukaryotes.


  • An estrogen sensor for poultry sex sorting1

    by H. T. Tran, W. Ferrell, T. R. Butt

    The need to segregate poultry based on sex is driven by sex-related differences in growth rate, market age, management practices, and nutritional requirements. Each day, poultry industry staff globally would ideally like to determine the sex of >150 million newly hatched birds. Currently, this can be done only manually at the hatchery, which is a virtually impossible undertaking. It is becoming more difficult each year to conduct manual sexing because this skill is disappearing from the workforce, is becoming unaffordable to the industry, and is encumbered by such negative effects as repetitive motion disorder. Automated sex sorting of eggs before hatching could resolve many, if not all, of these problems. We have developed a facile, rapid, and low-cost yeast-based assay that distinguishes male from female embryonated eggs before hatching based on the estrogen concentration of their allantoic fluid. Herein, we describe this novel sex-sorting technology, which we believe offers the potential to standardize and automate sex sorting in the poultry industry. Copyright © 2010. American Society of Animal Science .


  • Enhanced protein expression in mammalian cells using engineered SUMO fusions: Secreted phospholipase A2

    by Raymond J. Peroutka, Nabil Elshourbagy, Tara Piech, Tauseef R. Butt

    SUMOylation, the covalent attachment of SUMO (small ubiquitin‐like modifier), is a eukaryotic post‐translational event that has been demonstrated to play a critical role in several biological processes. When used as an N‐terminal tag or fusion partner, SUMO has been shown to enhance functional protein production significantly by improving folding, solubility, and stability. We have engineered several SUMOs and, through their fusion, developed a system for enhancing the expression and secretion of complex proteins. To demonstrate the fidelity of this fusion technology, secreted phospholipase A2 proteins (sPLA2) were produced using HEK‐293T and CHO‐K1 cells. Five mouse sPLA2 homologs were expressed and secreted in mammalian cell cultures using SUMO or SUMO‐derived, N‐terminal fusion partners. Mean and median increases of 43‐ and 18‐fold, respectively, were obtained using novel SUMO mutants that are resistant to digestion by endogenous deSUMOylases.


  • Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO

    by Jeffrey G. Marblestone, Suzanne C. Edavettal, Yiting Lim, Peter Lim, Xun Zuo, Tauseef R. Butt

    Despite the availability of numerous gene fusion systems, recombinant protein expression in Escherichia coli remains difficult. Establishing the best fusion partner for difficult‐to‐express proteins remains empirical. To determine which fusion tags are best suited for difficult‐to‐express proteins, a comparative analysis of the newly described SUMO fusion system with a variety of commonly used fusion systems was completed. For this study, three model proteins, enhanced green florescent protein (eGFP), matrix metalloprotease‐13 (MMP13), and myostatin (growth differentiating factor‐8, GDF8), were fused to the C termini of maltose‐binding protein (MBP), glutathione S‐transferase (GST), thioredoxin (TRX), NUS A, ubiquitin (Ub), and SUMO tags. These constructswere expressed in E. coli and evaluated for expression and solubility. As expected, the fusion tags varied in their ability to produce tractable quantities of soluble eGFP, MMP13, and GDF8. SUMO and NUS A fusions enhanced expression and solubility of recombinant proteins most dramatically. The ease at which SUMO and NUS A fusion tags were removed from their partner proteins was then determined. SUMO fusions are cleaved by the natural SUMO protease, while an AcTEV protease site had to be engineered between NUS A and its partner protein. A kinetic analysis showed that the SUMO and AcTEV proteases had similarKM values, but SUMOprotease had a 25‐fold higher kcat than AcTEV protease, indicating a more catalytically efficient enzyme. Taken together, these results demonstrate that SUMO is superior to commonly used fusion tags in enhancing expression and solubility with the distinction of generating recombinant protein with native sequences.


  • Enhanced Expression and Purification of Membrane Proteins by SUMO Fusion in Escherichia coli

    by Xun Zuo, Shuisen Li, John Hall, Michael R. Mattern, Hiep Tran, Joshua Shoo, Robin Tan, Susan R. Weiss, Tauseef R. Butt

    Severe acute respiratory syndrome coronavirus (SARS-CoV) membrane protein and 5-lipoxygenase-activating protein (FLAP) are among a large number of membrane proteins that are poorly expressed when traditional expression systems and methods are employed. Therefore to efficiently express difficult membrane proteins, molecular biologists will have to develop novel or innovative expression systems. To this end, we have expressed the SARS-CoV M and FLAP proteins in Escherichia coli by utilizing a novel gene fusion expression system that takes advantage of the natural chaperoning properties of the SUMO (small ubiquitin-related modifier) tag. These chaperoning properties facilitate proper protein folding, which enhances the solubility and biological activity of the purified protein. In addition to these advantages, we found that SUMO Protease 1, can cleave the SUMO fusion high specificity to generate native protein. Herein, we demonstrate that the expression of FLAP and SARS-CoV membrane proteins are greatly enhanced by SUMO fusions in E. coli.


  • Top Cited Papers

    SUMO fusion technology for difficult-to-express proteins

    by Tauseef R. Butt, Suzanne C. Edavettal, John P. Hall, Michael R. Mattern


  • Expression and purification of SARS coronavirus proteins using SUMO-fusions

    by Xun Zuo, Michael R. Mattern, Robin Tan, Shuisen Li, John Hall, David E. Sterner, Joshua Shoo, Hiep Tran, Peter Lim, Stefan G. Sarafianos, et al.


  • SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins

    by Michael P. Malakhov, Michael R. Mattern, Oxana A. Malakhova, Mark Drinker, Stephen D. Weeks, Tauseef R. Butt

    SUMO (small ubiquitin-related modifier) modulates protein structure and function by covalently binding to the lysine side chains of the target proteins. Yeast cells contain two SUMO proteases, Ulp1 and Ulp2, that cleave sumoylated proteins in the cell. Ulp1 (SUMO protease 1) processes the SUMO precursor to its mature form and also de-conjugates SUMO from side chain lysines of target proteins. Here we demonstrate that attachment of SUMO to the N-terminus of under-expressed proteins dramatically enhances their expression in E. coli. SUMO protease 1 was able to cleave a variety of SUMO fusions robustly and with impeccable specificity. Purified recombinant SUMO-GFPs were efficiently cleaved when any amino acid, except proline, was in the +1 position of the cleavage site. The enzyme was active over a broad range of buffer and temperature conditions. Purification of certain recombinant proteins is accomplished by production of Ub-fusions from which Ub can be subsequently removed by de-ubiquitinating enzymes (DUBs). However, DUBs are unstable enzymes that are difficult to produce and inexpensive DUBs are not available commercially. Our findings demonstrate that SUMO protease 1/SUMO-fusion system may be preferable to DUB/Ub-fusion. Enhanced expression and solubility of proteins fused to SUMO combined with broad specificity and highly efficient cleavage properties of the SUMO protease 1 indicates that SUMO-fusion technology will become a useful tool in purification of proteins and peptides. Abbreviations DUB, de-ubiquitinating enzyme or ubiquitin specific protease/hydrolase; GFP, green fluorescent protein; IPTG, isopropropyl-β-d-thiogalactopyranoside; MBP, E. coli maltose-binding protein; Ni-NTA, nickel-nitrilotriacetic acid; PCR, polymerase chain reaction; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; Ub, ubiquitin; Ubl(s), ubiquitin like protein(s); ULP, catalytic domain of Ulp1 or SUMO protease 1.